Intra-Cellular Therapies ... (ITCI)
NASDAQ: ITCI
· Real-Time Price · USD
131.87
0.00 (0.00%)
At close: Apr 01, 2025, 3:59 PM
Intra-Cellular Therapies Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 680.64M | 612.92M | 563.57M | 512.31M | 462.18M | 418.1M | 364.16M | 309.11M | 249.13M | 187.22M | 136.95M | 100.88M | 81.71M | 68.6M | 54.36M | 37.23M |
Cost of Revenue | 56.96M | 47.26M | 41.09M | 36.89M | 33.74M | 29.83M | 26.55M | 24.04M | 20.44M | 16.19M | 12.34M | 9.73M | 8.03M | 6.64M | 5.19M | 3.28M |
Gross Profit | 623.67M | 565.66M | 522.49M | 475.42M | 428.43M | 388.27M | 337.61M | 285.07M | 228.69M | 171.02M | 124.61M | 91.15M | 73.67M | 61.96M | 49.17M | 33.95M |
Operating Income | -116.72M | -121.62M | -112.48M | -131.94M | -159.38M | -172.7M | -198.61M | -239.36M | -263.63M | -302.22M | -323.91M | -305.13M | -285.69M | -261.02M | -239.63M | -235.36M |
Interest Income | 42.52M | 36.49M | 29.09M | 22.06M | 20.34M | 17.76M | 14.39M | 11.18M | 7.38M | 4.26M | 2.53M | 1.63M | 1.57M | 1.94M | 2.3M | 3.04M |
Pretax Income | -74.2M | -85.13M | -83.4M | -109.88M | -139.04M | -154.93M | -184.22M | -228.18M | -256.25M | -297.96M | -321.38M | -303.5M | -284.12M | -259.08M | -237.33M | -232.32M |
Net Income | -74.68M | -86.37M | -84.3M | -110.87M | -139.67M | -148.35M | -177.6M | -218.78M | -246.84M | -295.32M | -318.72M | -303.5M | -284.13M | -259.09M | -237.37M | -232.34M |
Selling & General & Admin | 504.49M | 471.48M | 444.59M | 424.03M | 409.86M | 399.77M | 382.94M | 382.25M | 358.78M | 343.83M | 325.95M | 295.49M | 272.61M | 251.28M | 233.26M | 204.85M |
Research & Development | 236.12M | 216.61M | 191.34M | 184.95M | 180.14M | 163.23M | 154.95M | 143.7M | 134.72M | 130.31M | 124.07M | 102.83M | 88.85M | 73.68M | 56.93M | 64.84M |
Other Expenses | -216K | -216K | n/a | n/a | -575K | -1.01M | -1.01M | -1.52M | -1.18M | -900.9K | -1.5M | -2.04M | -2.1M | -1.99M | -1.39M | -380.69K |
Operating Expenses | 740.39M | 687.28M | 634.97M | 607.36M | 587.81M | 560.97M | 536.22M | 524.42M | 492.31M | 473.24M | 448.52M | 396.28M | 359.36M | 322.97M | 288.8M | 269.31M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | 92.2M | 92.2M | 92.2M | 92.2M | 85.8M | 85.8M | 85.8M | 85.8M | 82.5M | 82.5M | 82.5M | 82.5M | 17.7M | 30.9M | 35M |
Cost & Expenses | 797.36M | 734.54M | 676.05M | 644.25M | 621.56M | 590.8M | 562.77M | 548.46M | 512.76M | 489.43M | 460.86M | 406.02M | 367.4M | 329.61M | 293.99M | 272.59M |
Income Tax Expense | 473K | 1.24M | 907K | 985K | 636K | -6.58M | -6.63M | -9.4M | -9.41M | -3.18M | -3.2M | -535.6K | -535.6K | 15.86K | 38.99K | 15.23K |
Shares Outstanding (Basic) | 103.13M | 105.77M | 103.72M | 96.88M | 96.29M | 96.14M | 95.95M | 95.13M | 94.75M | 93.87M | 94.13M | 92.46M | 81.48M | 81.35M | 81.23M | 80.95M |
Shares Outstanding (Diluted) | 103.13M | 105.77M | 103.72M | 96.88M | 96.29M | 96.14M | 95.95M | 95.13M | 94.75M | 94.52M | 94.29M | 92.6M | 81.48M | 81.35M | 81.23M | 80.95M |
EPS (Basic) | -0.01 | -0.87 | -0.87 | -1.16 | -1.46 | -1.55 | -1.87 | -2.31 | -2.63 | -3.29 | -3.67 | -3.63 | -3.5 | -3.21 | -3.05 | -3.16 |
EPS (Diluted) | -0.01 | -0.87 | -0.87 | -1.16 | -1.46 | -1.55 | -1.87 | -2.31 | -2.63 | -3.29 | -3.67 | -3.63 | -3.5 | -3.21 | -3.05 | -3.16 |
EBITDA | -116.35M | -121.22M | -111.95M | -131.41M | -158.85M | -172.16M | -198.04M | -238.74M | -262.97M | -301.56M | -323.29M | -304.55M | -285.15M | -260.5M | -239.13M | -234.85M |
EBIT | -116.72M | -121.62M | -112.48M | -131.94M | -159.38M | -172.7M | -198.61M | -239.36M | -263.63M | -302.22M | -323.91M | -305.13M | -285.69M | -261.02M | -239.63M | -235.36M |
Depreciation & Amortization | 508K | 535K | 532K | 526K | 528K | 535K | 570K | 619K | 656K | 659.83K | 623.77K | 577.35K | 533.36K | 512.51K | 499.61K | 506.32K |